Thermo Fisher finally lands Qiagen with $11.5B deal
After months of a public back-and-forth over a potential acquisition, Thermo Fisher Scientific President and CEO Marc Casper said he and Qiagen’s leadership finally had a “meeting of the minds” on how to move forward—and $11.5 billlion later, they’ve set a target date for the first half of 2021.
Sourced through Scoop.it from: www.fiercebiotech.com
Who We Are
Omnica Corporation is a privately-held design, engineering, and medical product development firm located in Irvine, California. The 28-person company is staffed with full-time employees and has been in operation since 1984. Our speciality is custom product development for the medical industry and industrial fields.
Our expertise is developing complex medical devices.Technical personnel at Omnica includes designers, mechanical engineers, electronic and software engineers, advanced R&D specialists, regulatory staff (for FDA documentation), machinists and model makers.